Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06091527 · ClinicalTrials.gov registry record · NA
Treating Major Depression With Yoga Mono-therapy
A NA study of Depression Mild and Depression Moderate, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06091527: Recruiting NA study of Depression Mild and Depression Moderate, sponsored by University of California, San Francisco.
NCT06091527 is a NA study of Depression Mild and Depression Moderate that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 180 participants, below the 415-participant average among 7 other Depression Mild trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06091527, a NA study of Depression Mild and Depression Moderate, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
Primary Outcome
The Beck Depression Inventory-II is one of the most commonly used instruments in psychiatric research; it has been translated and validated in many different languages, appearing in hundreds of studies worldwide. The Beck Depression Inventory-II is a 21-item validated instrument for the self-report of depressive symptoms; it can typically be completed in 5 minutes. Each item on the Beck Depression Inventory-II can be scored from 0 to 3, with the total score derived by summing the individual item
Conditions Studied
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Yoga practice
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-10-25 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06091527 shows while recruiting
NCT06091527 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 415-participant average among 7 other Depression Mild trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Depression Mild appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.
NCT06091527 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06091527 about?
NCT06091527 is a clinical study titled "Treating Major Depression With Yoga Mono-therapy". The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco G...
What is the current status of trial NCT06091527?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-10-25. Estimated completion is 2026-06.
What conditions does trial NCT06091527 study?
This clinical trial studies the following conditions: Depression Mild, Depression Moderate.
What interventions are being tested in trial NCT06091527?
The interventions under investigation include: Education (BEHAVIORAL), Yoga practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT06091527?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06091527 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression Mild
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
fMRI Neurofeedback With Matter Neuroscience App
RECRUITING · NA
-
Telehealth Behavioral Activation for Teens
RECRUITING · NA
-
Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2
ACTIVE NOT RECRUITING · NA
-
The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens
COMPLETED · NA
-
Kintsugi Voice Device Pivotal Study
RECRUITING
-
Kintsugi Voice Device Pilot Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI